Envoy MedicalCOCH +15.77%24 Gross Margin % is -702.56% as of Mar. 2026. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.14 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Envoy Medical ranks worse than 99.25% on this metric.
The historical rank and industry rank for Envoy Medical's Gross Margin % or its related term are showing as below:
COCH'
s Gross Margin % Range Over the Past 10 Years
Min: -310.68 Med: -149.68 Max: -110.13
Current: -310.68
During the past 5 years, the highestGross Margin % of Envoy Medical was -110.13%. The lowest was -310.68%. And the median was -149.68%.
COCH's Gross Margin % is ranked worse than 99.25% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs COCH: -310.68
Envoy Medical had a gross margin of -702.56% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Envoy Medical was 0.00% per year.
Envoy Medical (NAS:COCH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Envoy Medical had a gross margin of -702.56% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Envoy Medical Gross Margin % Related Terms
Envoy Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Envoy Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COCH vs SRTS, QTI, MDAI: Gross Margin % Comparison
For the Medical Devices subindustry, Envoy Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envoy Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Envoy Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Envoy Medical (COCH) has a Gross Margin % of -702.56% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Envoy Medical and its competitors. According to the industry distribution chart, Envoy Medical ranks #799 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 99.3%.
Is Envoy Medical's Gross Margin % too high?
Envoy Medical's current Gross Margin % is -702.56%. Based on the distribution chart, Envoy Medical ranks #799 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Gross Margin % compare to SRTS and QTI?
According to the Medical Devices & Instruments industry distribution chart, Envoy Medical ranks #799 out of 805 companies for Gross Margin %. This places Envoy Medical in the lower half of its industry. The industry median Gross Margin % is 51.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Envoy Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envoy Medical's current Gross Margin % is -702.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.14, compared to a current price of $0.78 — trading 31.7% below its estimated fair value. The current Gross Margin % is -702.56%. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Envoy Medical (COCH), the current Gross Margin % is -702.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envoy Medical (COCH) Overvalued in 2026?
Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued.
The current stock price of $0.78 is trading 31.7% below its estimated GF Value™ of $1.14.
GuruFocus considers Envoy Medical to be Possible Value Trap.
Key valuation signals for COCH:
Gross Margin %: -702.56%
GF Value™: $1.14 vs. price of $0.78 (31.7% below fair value)
No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score
Get the complete analysis for COCH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COCH has been successfully added to your 
